Sermorelin
Overview
Sermorelin is a shortened, synthetic version of growth hormone-releasing hormone (GHRH) covering the portion of the molecule needed to bind its receptor. It has a longer history of clinical use than most peptides in this category, including past pharmaceutical approval for diagnosing and treating growth hormone deficiency in children. It works upstream of growth hormone itself, prompting the pituitary to produce more of its own.
Dosing
See the general Dosing Guide for reconstitution and administration basics.
Further Reading
This page is a general summary, not a literature review. For primary research on Sermorelin, the National Library of Medicine's PubMed database is the standard starting point for peer-reviewed studies:
Search PubMed for Sermorelin research →